SPECTROstar Nano Absorbance Plate Reader

The quantification of nucleic acids (DNA and RNA) is a central step in molecular biology as downstream experiments rely on the use of adequate amounts. Following this, it is also crucial to determine the purity of DNA as it can affect the success of downstream processes.

Explore BMG LABTECH microplate readers equipped with a UV/vis spectrometer that can record full absorbance spectra (220–1000 nm) in less than 1 s/well. Discover how you can save significant time and easily assess nucleic acid quality with the simultaneous recording of multiple wavelengths.

Download this application note to find out how UV-Vis scanning and 'fingerprint' detection enables quality testing and authentication of distilled spirits, and how the SPECTROstar®Nano rapidly and efficiently measures multiple samples of distilled spirits.

In this application note, BMG LABTECH describes the successful implementation of the SimpleStep ELISA® kits and analysis with the SPECTROstar Nano® Absorbance Plate Reader for detection of 3 relevant biomarkers: Programmed Death Ligand 1 (PD-L1), Interleukin-8 (IL-8), and Interferon Gamma (IFN-γ).

This application note describes the detection of three Alzheimer’s Disease (AD) targets; Human BDNF (brain derived neurotrophic factor), Tau, and TREM2 (triggering receptor expressed in myeloid cells 2) for which changes in expression have been implicated in AD progression. Each of the analytes was tested using the SimpleStep ELISA® kits and detected with the SPECTROstar® Nano microplate reader.

The quantification of nucleic acids (DNA and RNA) is a central step in molecular biology as downstream experiments rely on the use of adequate amounts. In this application note, BMG LABTECH promises a fast and easy approach for data analysis to assess the quality of DNA/RNA samples using BMG LABTECH microplate readers.

THis application note describes the successful implementation of the SimpleStep ELISA® kits for detection of 3 relevant biomarkers: Programmed Death Ligand 1 (PD-L1), Interleukin-8 (IL-8), and Interferon Gamma (IFN-γ). Treatments targeting the Programmed Death 1 (PD-1) / PD-L1 pathway have seen successes due to the role of this pathway as an immune checkpoint. Beyond the immune regulator role, the expression level of PD-L1 in tumors, and in some instances, immune cells, has been correlated to the clinical outcome of blocking this pathway . In addition, both IL-82 and IFN-γ3 expression are shown to be modulated in response to PD-1/PD-L1-targeting treatments.

A book of application notes for all assay needs, using BMG LabTech Microplate Readers. This collection showcases the specific capabilities of the different models from the range of BMG LabTech Microplate Readers available.

In this application note, BMG Labtech discusses the benefit of using MARs with SPECTROstar for faster and easier data analysis. This application note highlights SimpleStep ELISA® kits that offer sensitivity and performance while saving significant time.

Metallic nanoparticles became subject of intensive research because of their potential antibiotic properties. This application note describes how the SPECTROstar® Nano can quickly confirm Ag and ZnO nanoparticle formation and their inhibitory effect on the diarrhea-causing bacteria Vibrio cholerae and enterotoxic Escherichia coli (ETEC).

This application note shows the power of UV-visible spectroscopy using the SPECTROstar Nano in quality control testing of distilled beverages, allowing distillers to detect counterfeits and track adulteration.

Discover tips and considerations for improving microplate reader measurements. Application specialists, Dr. Ann-Cathrin Volz and Dr. Martin Mangold from BMG LABTECH, discuss the impact of different plate reader parameters on data, and provide empirical evidence of their effect on data quality. They also discuss approaches to optimize microplate reader settings, and share recommendations for using BMG LABTECH's range of microplate readers.

From immunoassays and ELISAs to multi-mode microplate readers, discover the technologies making a difference for other scientists in your field

Trends in biomarker discovery methods and novel techniques advancing research, clinical diagnostics and therapeutic development